Credit Suisse: A Contrarian Buy (NYSE:CS)

Credit Suisse shares Drop Following Concern Over Financial Health

Dan Kitwood

Credit Suisse (NYSE:CS) has a depressed valuation that already reflects most of its fundamental issues, providing an opportunity for long-term (contrarian) investors to buy a deep value play that I think can perform quite well over the next

2023

CDS spread (Bloomberg)

2023

LCR ratio (Credit Suisse)

2023

Valuation (Bloomberg)

Be the first to comment

Leave a Reply

Your email address will not be published.


*